◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksE › EMSN

EMS-CHEMIE HOLDING AG (EMSN) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Basic Materials · Specialty Chemicals · DATA UPDATED 2026-08-16

EMS-CHEMIE HOLDING AG (EMSN) operates in the Specialty Chemicals industry and is headquartered in Domat/Ems, Switzerland with about 2,657 employees. Its market capitalization is roughly CHF 19 billion. In the fiscal year ended 2025-12-31, EMSN reported CHF 1.9B in revenue and CHF 466M in net income.

EMS-CHEMIE HOLDING AG engages in the polymers and specialty chemicals businesses in the Americas, Europe, Asia, and internationally.

Interactive charts & full statements →

EMSN Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-31
Total RevenueCHF 1.9BCHF 2.1BCHF 2.2BCHF 2.4B
Gross ProfitCHF 969MCHF 970MCHF 889MCHF 1.0B
Operating Income (EBIT)CHF 568MCHF 540MCHF 493MCHF 611M
Net IncomeCHF 466MCHF 461MCHF 458MCHF 532M

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EMSN Free Cash Flow History

Cash flow2025-12-312024-12-312023-12-312022-12-312021-12-31
Dividends Paid(CHF 404M)(CHF 374M)(CHF 468M)(CHF 491M)

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

EMSN Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCHF 2.2BCHF 2.2BCHF 2.2BCHF 2.3B
Total LiabilitiesCHF 368MCHF 362MCHF 399MCHF 472M

CHF; CHFM / CHFB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EMSN viewer.

Other Companies in Specialty Chemicals

← EMRAll “E” companiesEMXC →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.